General Submission Requirements
Journal of Clinical Medicine and Intelligent Healthcare (JCMIH) welcomes original and scientifically rigorous manuscripts that fall within the journal's Aims & Scope and contribute to the advancement of clinical medicine, intelligent healthcare, medical technologies, digital health, and their interdisciplinary applications.
Manuscripts submitted to JCMIH must comply with the following general requirements:
- § Originality and exclusive submission. Manuscripts must represent original scholarly work and must not have been previously published in substantially the same form or be under consideration for publication elsewhere. Previous dissemination as a preprint, conference paper, thesis or dissertation does not automatically preclude submission, provided that it is fully disclosed and complies with the journal's Preprints and Conference Papers Policy.
- § Language. Manuscripts must be written in clear and academically appropriate British English. Authors are responsible for ensuring the linguistic quality of their manuscript before submission. The Editorial Team may request language revision where the quality of English substantially affects readability or scientific clarity.
- § Manuscript preparation. Submissions must be prepared using the JCMIH Manuscript Template and submitted in an editable Microsoft Word (.docx) format. Manuscripts that substantially depart from the journal's formatting and structural requirements may be returned to the authors for technical revision before editorial assessment.
- § Manuscript length. JCMIH does not impose a fixed page limit. Manuscript length should be proportionate to the study design, methodological complexity, and scientific contribution. Manuscripts should be concise and free from unnecessary repetition.
- § Number of authors. JCMIH does not impose a fixed maximum number of authors. All listed authors must meet the journal's authorship criteria, and their individual contributions must be transparently reported using the CRediT taxonomy.
- § Scientific and methodological quality. Manuscripts should present a clearly defined research objective or question, an appropriate and reproducible methodology, transparent reporting of results, and conclusions supported by the evidence presented. Where applicable, authors must follow the relevant reporting guidelines for the study design.
- § Ethical compliance. Research involving human participants, patients, identifiable human data, human biological material, or animals must comply with applicable ethical and legal requirements. Where required, appropriate ethical approval or exemption and informed consent must have been obtained and clearly reported in the manuscript. Requirements concerning ethical approval, informed consent, patient privacy, and identifiable material are specified in the relevant sections of these Authors' Guidelines.
- § Clinical research transparency. Where applicable, clinical trials must comply with the journal's registration requirements, and the name of the registry and registration number must be reported in the manuscript.
- §Authorship. All listed authors must have made a qualifying contribution to the work, have reviewed and approved the submitted manuscript, and agree to be accountable for their respective contributions. Individual author contributions must be transparently reported using the CRediT (Contributor Roles Taxonomy). Detailed authorship and contributor requirements are provided under Authorship and Publication Declarations.
- § Corresponding Author. One author must be designated as the Corresponding Author and is responsible for communication with the Editorial Office throughout submission, peer review, revision, and publication. The Corresponding Author is also responsible for ensuring that all co-authors have approved the manuscript and the information provided during submission.
- § Conflicts of Interest and Funding. All relevant financial and non-financial conflicts of interest and all sources of financial or material support must be transparently disclosed in the manuscript.
- § Data Availability Statement (DAS). All manuscripts submitted to JCMIH must include a Data Availability Statement. The statement should clearly indicate whether the data supporting the findings are publicly available, available upon reasonable request, subject to ethical, privacy, legal or institutional restrictions, obtained from third parties, or whether no new data were generated or analysed. Authors should use the appropriate formulation provided in the manuscript template.
- § Ethical Approval Statement (EAS). All manuscripts must include an Ethical Approval Statement indicating whether ethical approval was required. Where applicable, authors must identify the approving Ethics Committee or Institutional Review Board, institution, approval/reference number and relevant approval information. Studies for which ethical approval was not required or was formally waived must state this clearly and provide the appropriate justification. Study-specific formulations are provided in the manuscript template.
- § Consent for Publication. Where a manuscript contains identifiable patient information, clinical images, photographs, videos or other material that could permit identification of an individual, written consent for publication must be obtained from the patient or their legally authorized representative. Where no identifiable information is presented, this should be indicated as not applicable. Authors should follow the formulation provided in the manuscript template.
- § Clinical Trial Registration. Manuscripts reporting clinical trials must provide the name of the trial registry, registration number and registration date. Where clinical trial registration is not applicable, this should be stated accordingly.
- § Use of AI-assisted technologies. Authors must disclose any use of generative AI or AI-assisted technologies in the preparation of the manuscript. AI tools cannot be listed as authors, and the human authors remain fully responsible for the accuracy, originality and integrity of the submitted work. The appropriate declaration provided in the manuscript template should be used.
- § Third-party material. Authors are responsible for obtaining any permissions required to reproduce or adapt copyrighted material from other sources and for providing appropriate acknowledgements and credit lines.
Submission of a manuscript to JCMIH implies that all authors have read and accepted the journal's editorial, ethical, open access, copyright, licensing, and peer-review policies.
Submission Format
Unless otherwise specified for a particular article type, manuscripts should be submitted as a single editable Word file containing the complete text, tables, figures, captions, declarations, and references. Supplementary material, where applicable, should be clearly identified and submitted separately.
Authors should ensure that the manuscript contains all mandatory declarations relevant to the study, including, where applicable:
CRediT Authorship Contribution Statement • Acknowledgments • Funding Statement • Conflict of Interest Statement • Data Availability Statement • Ethical Approval Statement • Consent Statement • Clinical Trial Registration • AI Use Disclosure.
Article Types and Requirements
Journal of Clinical Medicine and Intelligent Healthcare (JCMIH) publishes original, methodologically rigorous, and clinically or scientifically relevant contributions within the journal's scope. Authors should select the article type that best reflects the design, objectives, and contribution of their manuscript.
All submissions must comply with the journal's general requirements and, where applicable, with relevant ethical and reporting standards.
§ Original Research Articles
Original Research Articles report novel findings derived from clinical, observational, experimental, diagnostic, prognostic, medical imaging, technological, computational, or other methodologically rigorous research. This category also includes clinical trials and research involving artificial intelligence or machine learning applications in medicine and healthcare.
Original Research Articles should normally follow an IMRaD-based structure: Introduction – Materials and Methods – Results – Discussion – Conclusions
The Materials and Methods section must provide sufficient information to allow readers to assess the validity and reproducibility of the study. Authors should describe, as applicable, the study design, setting, participants or data sources, inclusion and exclusion criteria, interventions or exposures, outcome measures, data collection procedures, statistical or computational methods, and ethical considerations.
For studies involving artificial intelligence, machine learning, medical imaging, predictive modelling, or other computational approaches, authors must provide sufficient methodological detail regarding data sources, data preparation, model development, training and validation procedures, performance assessment, and other elements necessary to evaluate the reliability, reproducibility, and potential clinical relevance of the findings.
Clinical trials must comply with the journal's Clinical Trial Registration requirements.
§ Review Articles
Review Articles provide a critical, balanced, and up-to-date synthesis of the existing literature on a clearly defined topic relevant to the scope of JCMIH.
Reviews should extend beyond a descriptive summary of previous research and provide critical analysis of the available evidence, identifying major developments, methodological limitations, controversies, knowledge gaps, and implications for future research, clinical practice, healthcare innovation, or policy, as appropriate.
The approach used to identify, select, and evaluate the literature should be described sufficiently to allow readers to understand the basis of the review.
§ Systematic Reviews and Meta-Analyses
Systematic Reviews and Meta-Analyses must address a clearly formulated research question and employ a transparent and reproducible methodology for literature searching, study selection, data extraction, assessment of study quality or risk of bias, and evidence synthesis.
Authors should follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) reporting guideline and provide the relevant checklist and flow diagram, where applicable. Where a systematic review or meta-analysis protocol has been prospectively registered, the registry and registration number should be reported in the manuscript.
§ Case Reports and Case Series
Case Reports and Case Series should present clinically relevant, educational, unusual, or novel observations that contribute meaningfully to medical knowledge, diagnosis, treatment, clinical decision-making, or understanding of disease.
The manuscript should provide sufficient clinical context, relevant patient information, diagnostic assessment, therapeutic intervention or management, follow-up and outcomes, where applicable, and a focused discussion placing the case or case series within the context of the existing literature. Authors should follow the CARE (Case Report) Guidelines, where applicable.
Appropriate consent for publication must be obtained where the manuscript contains identifiable patient information, clinical images, photographs, videos, or other material that could permit identification of an individual. The applicable declaration must be included in the manuscript in accordance with the Manuscript Template, which already provides the corresponding Consent for Publication statement.
§ Methodological and Technical Articles
Methodological and Technical Articles describe, develop, or evaluate novel or substantially improved methods, diagnostic approaches, medical technologies, clinical software, algorithms, intelligent healthcare systems, imaging techniques, devices, digital health solutions, or other tools relevant to the scope of JCMIH.
The manuscript should clearly describe the methodological or technological innovation, its intended clinical or healthcare application, validation procedures, performance, limitations, and potential advantages in comparison with existing approaches.
For artificial intelligence and machine learning applications, technical performance alone is not sufficient. Authors should address the clinical or healthcare relevance of the proposed approach, the appropriateness of validation, limitations of the model or technology, and its potential applicability and generalisability in real-world settings.
§ Short Communications
Short Communications report concise but scientifically relevant original findings that warrant timely dissemination but do not require presentation as a full Original Research Article.
They should include a clearly defined objective, an appropriate and sufficiently described methodology, relevant results, and a focused discussion and conclusion. The shorter format does not imply reduced standards of scientific, methodological, ethical, or reporting quality. Preliminary observations without sufficient supporting evidence will not normally be considered for publication.
§ Editorials
Editorials provide scholarly perspectives on timely clinical, scientific, technological, ethical, or healthcare policy issues relevant to the scope of JCMIH. They may also introduce, contextualize, or critically discuss topics addressed within a particular journal issue. Editorials are generally commissioned or invited by the Editorial Team. Unsolicited Editorials may be considered at the discretion of the Editor-in-Chief.
Manuscript Preparation and Editorial Standards
Manuscripts submitted to Journal of Clinical Medicine and Intelligent Healthcare (JCMIH) must be prepared in accordance with the JCMIH Manuscript Template and should meet the journal's standards of scientific quality, clarity, originality, and research integrity.
§ Language and Writing Style
Manuscripts must be written in clear, grammatically correct academic English. Authors are responsible for ensuring that the language is of publication quality before submission.
Papers should generally be written in the third person to maintain a formal and objective academic tone. First-person constructions may be used where appropriate for methodological clarity, but informal, conversational, promotional, or subjective language should be avoided.
Examples:
- - Third Person: "A study was conducted to investigate the influence of variable X on variable Y."
- - First-Person Plural: "We conducted a study to investigate the influence of variable X on variable Y."
Terminology should be precise and consistent throughout the manuscript. Abbreviations should be defined at first use and used only where they improve readability.
§ Originality, Similarity and AI Screening
Manuscripts submitted to JCMIH must represent original scholarly work and must not contain plagiarised, improperly attributed, fabricated, falsified, or otherwise misrepresented material.
All submitted manuscripts are screened using Turnitin as part of the journal's editorial integrity assessment. As a general editorial standard, the overall similarity index should not exceed 10%, excluding properly cited references, bibliographic entries, standard methodological expressions, and other legitimate textual matches, as applicable. The similarity percentage is not interpreted mechanically. The Editorial Team evaluates the nature, source, distribution, and context of textual overlap, and manuscripts may be questioned or rejected even where the overall similarity index is below 10% if inappropriate or unattributed overlap is identified.
Turnitin screening also includes, where technically applicable, AI writing detection. AI-detection results are treated as editorial screening indicators and are subject to human evaluation; they do not, by themselves, constitute evidence of inappropriate AI use or research misconduct.
Authors must appropriately cite and acknowledge all material derived from previous sources. Substantial unattributed overlap, duplicate publication, inappropriate text recycling, or undisclosed use of AI that compromises the originality or integrity of the manuscript may result in further editorial investigation and, where warranted, rejection or other action in accordance with the journal's publication ethics procedures.
§ Disclosure of Interests
All authors must disclose any financial, professional, personal, institutional, or other relationships or interests that could reasonably be perceived as influencing the research, its interpretation, or its presentation.
A Conflict of Interest Statement must be included in every manuscript, including where no competing interests exist. Authors should use the appropriate formulation provided in the Manuscript Template. Authors are also required to confirm the disclosure of any actual or potential conflicts of interest in the JCMIH License and Publication Agreement prior to publication.
Funding sources and the role of funders, where applicable, must be reported separately in the Funding Statement section.
§ Use of AI and AI-Assisted Technologies
The use of Artificial Intelligence (AI), Generative AI, and AI-assisted technologies in manuscript preparation must comply with the RITHA Publishing AI and Generative Technologies Policy.
Authors may use AI-assisted technologies for legitimate scholarly purposes, but remain fully responsible for the accuracy, originality, integrity, and scientific validity of all submitted content. AI systems, Large Language Models, chatbots, or other AI technologies cannot be listed as authors or co-authors.
Where AI or Generative AI tools have made a substantive contribution to the preparation of the manuscript, authors must disclose their use, identifying the tool used, the purpose of its use, and the extent of its contribution. Routine spelling, grammar, and formatting tools generally do not require disclosure. The appropriate Declaration of Generative AI and AI-Assisted Technologies in the Writing Process must be included in the declarations section before the References using the formulation provided in the JCMIH Manuscript Template.
§ Manuscript Organisation and Formatting
Authors must prepare their manuscript using the official JCMIH Manuscript Template. The appropriate organisation of the manuscript depends on the article type and study design. Authors should therefore follow both the requirements applicable to the selected article type and the structure provided in the Template. JCMIH does not impose a fixed page limit. Manuscripts should nevertheless be concise, logically organised, and proportionate to the methodological complexity and scientific contribution of the study.
Detailed requirements concerning title and author information, abstract and keywords, headings and sections, tables and figures, citations and references, and end-of-manuscript declarations are provided directly in the JCMIH Manuscript Template.
§ Scientific and Methodological Clarity
The research question, objectives, study design, methods, results, and conclusions must be presented clearly and consistently.
Methods should be described with sufficient detail to permit critical assessment of the study and, where feasible, reproducibility. Conclusions must be supported by the results and should not extend beyond the evidence presented.
Authors should avoid unnecessary repetition between the Abstract, Introduction, Results, Discussion, and Conclusions.
§ Use of Abbreviations, Units and Terminology
Abbreviations and acronyms should be used sparingly and defined at first occurrence. Standard internationally recognised abbreviations may be used where appropriate. Measurements should be reported using internationally accepted units, preferably the International System of Units (SI), where applicable. Medical and scientific terminology should be accurate, current, and used consistently throughout the manuscript.
Reporting and Research Standards
JCMIH requires research to be reported in a complete, transparent, and reproducible manner. Authors should follow internationally recognised reporting guidelines appropriate to the study design, methodology, and clinical or technological application.
Authors are responsible for identifying and applying the reporting guideline most appropriate to their study. Where a guideline includes a checklist or flow diagram, the Editorial Team may request the completed document as supplementary material during submission or peer review.
§ Reporting Guidelines by Study Design
Where applicable, authors should follow the current version of recognised reporting guidelines, including: CONSORT – randomised controlled trials; STROBE – observational studies; PRISMA – systematic reviews and meta-analyses; CARE – case reports; STARD – diagnostic accuracy studies; TRIPOD – studies developing or validating clinical prediction models.
Authors should use the most appropriate current version or extension of the relevant reporting guideline for their particular study design.
§ Reporting Standards for Artificial Intelligence and Machine Learning Studies
Studies involving artificial intelligence, machine learning, deep learning, radiomics, medical image analysis, predictive modelling, clinical decision-support systems, or other computational healthcare applications must provide sufficient methodological transparency to permit critical evaluation and, where feasible, reproducibility.
In addition to general reporting standards, authors should follow AI-specific guidelines appropriate to the study design, including:
- - CONSORT-AI – clinical trial reports evaluating interventions with an AI component;
- - SPIRIT-AI – protocols for clinical trials involving AI interventions; CONSORT-AI was developed together with SPIRIT-AI specifically to cover trial reports and their protocols.
- - TRIPOD+AI – studies developing, evaluating, or validating clinical prediction models using regression or machine-learning methods; the updated guideline was published in 2024.
- - CLAIM (Checklist for Artificial Intelligence in Medical Imaging) – AI research involving medical imaging. Authors should use the current CLAIM 2024 Update, where applicable.
Authors should report, as applicable, the origin and characteristics of the data; eligibility and selection criteria; data preprocessing; handling of missing data; separation of training, validation, and test datasets; model or algorithm development; performance metrics; comparator methods; and internal and/or external testing or validation.
Potential sources of bias, overfitting, data leakage, and limitations in generalisability should be appropriately addressed. For medical imaging AI studies, CLAIM 2024 specifically emphasises reproducible methodology, intended clinical use, appropriate testing, and transparency concerning the availability of software, data, and/or resulting models.
Claims concerning diagnostic or predictive performance, clinical utility, generalisability, or readiness for clinical implementation must be proportionate to the evidence and level of validation presented.
This section concerns AI and computational technologies used as the subject or methodology of the research. The use of Generative AI or AI-assisted technologies in the writing or preparation of a manuscript is governed separately by the RITHA Publishing AI and Generative Technologies Policy and the disclosure requirements specified in Section 3.
§ Statistical Reporting
Statistical methods must be appropriate to the study design, research question, and characteristics of the data and should be described with sufficient detail to permit critical evaluation. Authors should, where applicable:
- - identify the statistical methods and software used;
- - report appropriate measures of effect and uncertainty, including confidence intervals where relevant;
- - provide exact p-values where appropriate rather than relying solely on significance thresholds;
- - describe the handling of missing data, multiple comparisons, repeated measurements, and other relevant analytical issues;
- - consider and report relevant assumptions underlying the statistical analyses;
- - distinguish between statistical significance and clinical significance.
Statistical findings should be interpreted in the context of the study design and available evidence. Conclusions must not extend beyond what is supported by the analyses performed.
§ Reproducibility and Methodological Transparency
Methods should be reported with sufficient detail to enable readers and reviewers to understand how the research was conducted, assess its reliability, and, where feasible, reproduce the study.
Authors should clearly identify relevant protocols, instruments, medical devices, software, algorithms, databases, datasets, and other methodological resources used in the research. Where appropriate and legally or ethically permissible, software versions, repository information, persistent identifiers, or other information facilitating reproducibility should be provided.
Any material deviation from a registered protocol, predefined analysis plan, or previously described methodology should be transparently reported and justified.
Research Ethics, Patient Protection and Data Integrity
JCMIH requires research to be conducted and reported in accordance with recognised principles of research integrity, applicable ethical and legal requirements, and the current Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE), updated January 2026.
Authors should consult the most recent version of the ICMJE Recommendations, as these standards are periodically updated.
ICMJE Recommendations – Updated January 2026
§ Ethical Approval
Research involving human participants, patients, identifiable human data, human biological material, or animals must comply with applicable ethical requirements and must receive appropriate ethical approval before the study is conducted, where such approval is required.
In accordance with the ICMJE Recommendations (updated January 2026), research involving human participants should be planned, conducted, and reported in accordance with the Declaration of Helsinki, as revised in 2024. Authors must obtain approval from an appropriate independent ethics committee or Institutional Review Board and should be prepared to provide documentation of such approval if requested by the Editorial Team.
All manuscripts must include an Ethical Approval Statement (EAS) indicating whether ethical approval was required. Where applicable, the statement should identify the approving Ethics Committee or Institutional Review Board, institution, and approval/reference number.
Where ethical approval was not required, was formally waived, or is not applicable to the type of research conducted, this must be clearly stated and appropriately justified.
§ Consent, Patient Privacy and Identifiable Material
The privacy, confidentiality, and dignity of patients and research participants must be protected.
Where a manuscript contains identifiable patient information, clinical photographs, medical images, videos, pedigrees, case histories, or other material from which an individual could reasonably be identified, authors must obtain written consent for publication from the patient or, where appropriate, their legally authorised representative.
Identifying information that is not scientifically necessary should not be published. Simple masking of identifying features may not always provide adequate anonymisation; the current ICMJE guidance specifically notes that masking only the eye region in a photograph is insufficient protection of anonymity.
Authors should retain appropriate documentation of consent and must be prepared to provide confirmation of consent to the Editorial Team if requested.
§ Clinical Trial Registration
Clinical trials must be registered in a publicly accessible and recognised clinical trial registry at or before the time of first participant consent/enrolment.
The manuscript must identify the registry, registration number, and registration date. Retrospective registration does not normally satisfy the principle of prospective trial registration. This aligns JCMIH with current ICMJE recommendations, which require prospective registration and recognise WHO ICTRP primary registries and ClinicalTrials.gov, among qualifying registries. Where clinical trial registration is not applicable, authors should use the appropriate statement provided in the JCMIH Manuscript Template.
§ Research Data and Data Availability
Authors are responsible for the accuracy, integrity, and appropriate management of the data underlying their research. JCMIH supports responsible research-data sharing and reproducibility while recognising legitimate restrictions arising from patient confidentiality, informed consent, ethics approvals, data-protection requirements, legal obligations, intellectual property, or institutional agreements.
Every manuscript must contain a Data Availability Statement (DAS). The statement should indicate whether supporting data are publicly available, available upon reasonable request, subject to legitimate restrictions, obtained from third parties, or whether no new data were generated or analysed. Where data are publicly deposited, authors should provide the repository and a persistent identifier or DOI, where available.
For clinical trials, authors should additionally ensure that their data-sharing statement and, where applicable, registered data-sharing plan meet relevant clinical-trial requirements. Current ICMJE guidance requires clinical-trial reports to include a data-sharing statement and specifies information such statements should address.
§ Data, Image and Research Integrity
Data, results, clinical images, medical images, figures, and other research materials must accurately represent the underlying research and must not be fabricated, falsified, selectively manipulated, or presented in a misleading manner.
Image adjustments must not obscure, remove, introduce, or selectively enhance information in a way that alters scientific interpretation. Where image processing is methodologically relevant, it should be transparently described.
The Editorial Team may request original data, unprocessed images, supporting documentation, ethics approval documentation, or other research records where necessary to assess the integrity of a submission.
Concerns regarding fabrication, falsification, inappropriate image manipulation, or other forms of research misconduct may result in further investigation and editorial action in accordance with the journal's publication ethics procedures.
Authors are required to confirm compliance with the applicable research ethics, informed consent, patient privacy, data integrity, and publication requirements through the JCMIH License and Publication Agreement prior to publication.
Authorship and Publication Declarations
JCMIH applies transparent authorship, contributor, disclosure, and publication practices consistent with the ICMJE Recommendations (updated January 2026) and the journal's own editorial and publication policies.
§ Authorship
Authorship must reflect genuine and substantive scholarly contributions to the work. All listed authors must have made a qualifying contribution, have reviewed and approved the submitted and final versions of the manuscript, and agree to be accountable for their respective contributions. Individuals whose contributions do not qualify for authorship should not be listed as authors but may be acknowledged, where appropriate and with their permission.
§ CRediT Authorship Contribution
JCMIH requires authors to specify their individual contributions using the CRediT (Contributor Roles Taxonomy). Authors should select the applicable contributor roles from the official CRediT taxonomy. Multiple roles may be assigned to the same author, and the same role may be shared by more than one author. The CRediT taxonomy describes individual contributions to the work but does not, by itself, determine eligibility for authorship. The Corresponding Author is responsible for ensuring that the contributions reported for all authors are complete and accurate and have been agreed upon by all co-authors.
Example:
CRediT Authorship Contribution: A.B.: Conceptualization, Methodology, Investigation, Writing – Original Draft. C.D.: Data Curation, Formal Analysis, Visualization. E.F.: Validation, Writing – Review & Editing. G.H.: Supervision, Project Administration, Writing – Review & Editing. All authors have read and approved the final version of the manuscript.
§ Corresponding Author Responsibilities
One author must be designated as the Corresponding Author and will act as the primary contact between the authors, Editorial Team, and Publisher throughout submission, peer review, revision, and publication.
The Corresponding Author is responsible for ensuring that all co-authors have approved the manuscript and its submission, that authorship and author order have been agreed upon, that CRediT contributions and required declarations are accurate and complete, and that all authors are informed of significant editorial decisions.
Prior to publication, the Corresponding Author must complete the JCMIH License and Publication Agreement and confirm that they are authorised to act on behalf of all co-authors.
§ Funding and Acknowledgments
All sources of financial support relevant to the research must be disclosed. Where applicable, authors should identify the funding organisation and grant or project number. Where no external funding was received, this should be stated explicitly. Individuals, institutions, or organisations that contributed to the work but do not qualify for authorship may be recognised in the Acknowledgments, where appropriate and with their permission.
The required formulations are provided in the JCMIH Manuscript Template.
§ Publication Declarations
All manuscripts must contain the declarations applicable to the study, including Conflict of Interest, Ethical Approval, Consent for Publication, Clinical Trial Registration, Data Availability, and disclosure of Generative AI or AI-Assisted Technologies, as applicable. The specific requirements governing these declarations are provided in the relevant sections of these Authors' Guidelines, while the JCMIH Manuscript Template provides the appropriate formats and model statements. Prior to publication, authors are also required to confirm compliance with the journal's authorship, originality, research ethics, disclosure, data integrity, and publication requirements through the JCMIH License and Publication Agreement.
Article Processing Charges (APC)
Journal of Clinical Medicine and Intelligent Healthcare (JCMIH) is a fully open access journal.
JCMIH does not charge authors any fees for manuscript submission, editorial processing, peer review, or publication. There are no Article Processing Charges (APCs), submission fees, page charges, or other publication fees applicable to authors.
All articles accepted for publication are made freely and permanently available online under the Creative Commons Attribution 4.0 International License (CC BY 4.0), without any charge to authors or readers.
Editorial decisions are made independently of any financial considerations and are based exclusively on the manuscript's scientific quality, methodological soundness, originality, relevance to the journal's scope, ethical compliance, and outcome of the peer-review process.
